Table 2.
Survival of anaplastic thyroid cancer patients in subgroups
| Parameter | Subgroups | Median overall survival (months) | p |
|---|---|---|---|
| All patients |
|
5 |
|
| Surgery |
Yes |
10.5 |
0.02 |
| No |
3 |
||
| N Stage |
N0 |
18.3 |
0.041 |
| N+ |
4.5 |
||
| M Stage |
M0 |
18.3 |
0.07 |
| M1 |
4 |
||
| Age |
<67 years |
5.5 |
0.39 |
| ≥67 years |
4 |
||
| Sex |
♀ |
5 |
0.66 |
| ♂ |
5 |
||
| Histology |
“Pure ATC” |
4.5 |
0.29 |
| “ATC with PDTC” |
10.5 |
||
| Total RT dose (Gy) |
≥50 |
10.5 |
0.02 |
| <50 |
3 |
||
| Resection status |
R2 |
3.6 |
0.41 |
| R0, R1 |
12.2 |
||
| Lymph node dissection |
Yes |
12.2 |
0.051 |
| No |
3 |
||
| Chemotherapy |
Yes |
4 |
0.85 |
| No | 5.5 |